ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Nicoletta Colombo(University of Milano-Bicocca), Alain G. Zeimet(Innsbruck Medical University), Stefano Greggi, Vesna Kesić, Antonio González-Martı́n(Spanish Ovarian Cancer Research Group), Alexandros Rodolakis, Frédéric Goffin(University of Liège), José María Del Campo, Günter Emons, Frédéric Amant(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Remi A. Nout(Erasmus MC Cancer Institute), Tjalling Bosse(Leiden University Medical Center), Dionyssios Katsaros(McGill University Health Centre), Christian Marth(Nordic Society of Gynecologic Oncology), Denis Querleu(Agostino Gemelli University Polyclinic), Miguel Abal, Antonio Casado(Hospital Clínico San Carlos), Sigurd Lax(Graz University Hospital), Philippe Morice(Inserm), Fabrice Lécuru(Université Paris Cité), Nicholas Reed, Domenica Lorusso(Agostino Gemelli University Polyclinic), Susana Banerjee(Royal Marsden NHS Foundation Trust), Christine Haie-Méder(Institut Gustave Roussy), Hans W. Nijman(University Medical Center Groningen), Xavier Matías‐Guiu(Universitat de Lleida), David Cibula(Charles University), Carien L. Creutzberg(Leiden University Medical Center), Melanie Powell(St Bartholomew's Hospital), Jonathan A. Ledermann(London Cancer), Mansoor Raza Mirza(C4 Therapeutics (United States)), Cristiana Sessa(Institute of Oncology Research), Özden Altundağ, Christian Kurzeder(Ospedale San Giovanni Bellinzona), Tally Levy, Helga B. Salvesen(Haukeland University Hospital), L Chiva de Agustín, Johanna Mäenpää, Antoni Van Leeuwenhoek, Jalid Sehouli(Charité - Universitätsmedizin Berlin)
Cited by 1,377
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k